Urinary Tract Infections (UTIs): Symptoms, Diagnosis, and Treatment
Understanding UTIs
UTIs are among the most common bacterial infections, affecting ~50–60% of women and ~12% of men lifetime. Prompt treatment prevents complications (pyelonephritis, sepsis).
Anatomy and Risk Factors
- Female anatomy: Short urethra (4 cm) near anus → easy bacterial ascent
- Sexual activity: "Honeymoon cystitis"—mechanical inoculation
- Menopause: Estrogen loss → vaginal pH ↑, lactobacilli ↓, urethral atrophy
- Anatomic/functional: Obstruction (stones, BPH, stricture), neurogenic bladder, incomplete emptying
- Instrumentation: Catheters, cystoscopy
- Immunosuppression: Diabetes, chemo, steroids
- Genetics: TLR4, CXCR1 variants affect susceptibility
Pathogens
- E. coli (75–90% community)
- Klebsiella, Proteus, Enterococcus, Pseudomonas, Staphylococcus saprophyticus (young women)
- Fungi (Candida)—catheters, immunocompromised
Clinical Syndromes
- Urethritis: Dysuria, urethral discharge. Often STI (GC, CT, MG, TV).
- Cystitis (lower UTI): Dysuria, frequency, urgency, suprapubic pain, hematuria. No fever.
- Pyelonephritis (upper UTI): Fever, flank pain, CVA tenderness, nausea/vomiting ± cystitis symptoms. Systemic illness.
- Asymptomatic bacteriuria (ASB): >10⁵ CFU/mL without symptoms. Treat ONLY in pregnancy, pre-urologic procedure. Otherwise → resistance.
Diagnosis
- Urinalysis: Leukocyte esterase, nitrites, WBC >5/HPF, bacteria
- Urine culture: Gold standard. ID + susceptibilities. Clean-catch midstream; catheterized if needed.
- Imaging: Not routine. If recurrent, pyelo, stones, hematuria, failed treatment → US/CT.
Treatment (IDSA/EAU Guidelines)
Uncomplicated Cystitis (Women)
- Nitrofurantoin 100 mg BID × 5 days (avoid if CrCl <30, G6PD)
- TMP-SMX DS BID × 3 days (if local resistance <20%)
- Fosfomycin 3 g single dose
- Pivmecillinam (non-US)
- Fluoroquinolones (cipro/levo)—reserve (collateral damage)
Complicated / Pyelonephritis / Men
- Fluoroquinolones (7–14 days) OR TMP-SMX (14 days) OR β-lactam (ceftriaxone → oral step-down)
- IV → PO switch when improving
- Duration: 7 days (complicated cystitis), 14 days (pyelo), longer if bacteremia
Recurrent UTIs (≥3/year or ≥2/6 months)
- Confirm culture-proven each episode
- Vaginal estrogen (postmenopausal)—highly effective
- Prophylaxis: postcoital single dose OR daily low-dose (TMP-SMX, nitrofurantoin, cephalexin) × 6–12 months
- Methenamine hippurate (non-antibiotic; urine formaldehyde)
- D-mannose, cranberry (PAC 36 mg)—modest evidence
- Urology eval if structural concern
Prevention
- Hydration (2–3 L/day)
- Void regularly (q3–4h), post-coital
- Front-to-back wiping
- Avoid irritants (douches, sprays, spermicides)
- Condoms (reduce bacterial inoculation)
- Probiotics (L. crispatus, L. rhamnosus)—emerging evidence
UTIs are treatable. Recurrent UTIs deserve a systematic workup—not just repeated antibiotics.
Urinary Disorders - Related Articles
- How Urea Diffusion Works in Dialysis: Principles and Factors Affecting Efficiency
- Acute Renal Failure: Understanding Symptoms, Causes & Treatment
- Nitrofurantoin for UTI & Yeast Infections: Diagnosis & Treatment
- Frequent Urination in Early Pregnancy: Causes and When to Check In
- Understanding Sulfur Odor in Urine: Causes & What It Means
- Urine Odor and Dysuria: Differential Diagnosis, Diagnostic Approach, and Treatment
- Understanding and Using a Urinary Catheter (Female)
